Head-to-Head Comparison
| Criteria | Omega-3 EPA | DHA | Winner |
|---|---|---|---|
| Absorption | Depends on formulation, dose and meal | Depends on formulation, dose and meal | Tie |
| Cardiovascular outcomes | Prescription icosapent ethyl has evidence in selected high-risk patients | DHA-containing supplements are a different intervention | Tie |
| Brain and eye claims | Participates in lipid and inflammatory pathways | An important structural fatty acid in brain and retina | Tie |
| Tolerability and cost | Product-specific; gastrointestinal effects are possible | Product-specific; gastrointestinal effects are possible | Tie |
| Depression research | EPA-rich subgroups showed a signal in a meta-analysis | DHA-rich subgroups did not show the same signal | Tie |